Cargando…
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important. Several immunoassays are available to measure sclerostin in s...
Autores principales: | Piec, Isabelle, Washbourne, Christopher, Tang, Jonathan, Fisher, Emily, Greeves, Julie, Jackson, Sarah, Fraser, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860200/ https://www.ncbi.nlm.nih.gov/pubmed/26749312 http://dx.doi.org/10.1007/s00223-015-0105-3 |
Ejemplares similares
-
Sclerostin
por: Silverman, Stuart L.
Publicado: (2010) -
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013) -
Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020) -
Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023) -
Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)